Anniek B van der Waart
10PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Feb 17, 2025
IL-15 transpresentation by ovarian cancer cells improves CD34+ progenitor-derived NK cell's anti-tumor functionality.M Vidal-Manrique, T Nieuwenstein, L Hooijmaijers
|Sep 20, 2023
Human CD34+-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8+ T cell and NK cell responses in vitro and in vivo.Jesper van Eck van der Sluijs, Diede van Ens, Jolanda Brummelman
|Oct 07, 2021
CD34+ progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rgnull mice.Jolien M R Van der Meer, Paul K J D de Jonge, Anniek B van der Waart
|Sep 15, 2021
Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells.J M R Van der Meer, R J A Maas, K Guldevall
|Apr 02, 2021
Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses.Jesper van Eck van der Sluijs, Diede van Ens, Soley Thordardottir
|Nov 03, 2020
IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells.J M R Van der Meer, R J A Maas, K Guldevall
Pageof 2
Frequent Collaborators
9 joint publications
Harry Dolstra
9 joint publications
Willemijn Hobo
8 joint publications
Joop H Jansen
7 joint publications
Nicolaas P M Schaap
3 joint publications
Jolien M R Van der Meer
3 joint publications
Ralph J A Maas
3 joint publications
Diede van Ens
3 joint publications
Janneke S Hoogstad-van Evert
3 joint publications
Charlotte M Mousset
2 joint publications
J Cany
